Share this article
Share this article
ATMA Journey Centers and SYNTAC Institute collaborate to submit a Group Application for Section 56 Exemption from Health Canada to access psychedelic-assisted therapy
CALGARY, AB, Feb. 2, 2021 /CNW/ -
ATMA Journey Centers Inc. (
ATMA ), an Alberta-based company focused on delivering innovative psychedelic-assisted therapies internationally, announced today that it has submitted a Group Application for Section 56 Exemption to Health Canada on behalf of Canadians struggling with adverse mental and emotional health conditions.
David Harder, Co-CEO of ATMA, said: We ve received close to 300 individual submissions from Canadians over the past 90 days who are struggling deeply with a wide range of psychological, mental and emotional conditions and distress. These are patients who have tried other options that have failed, and COVID-19 has only added to the challenges.